Kathrin Sprinzl
Goethe University Frankfurt(DE)University Hospital Frankfurt(DE)
Publications by Year
Research Areas
Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Inflammatory Bowel Disease, Eosinophilic Esophagitis
Most-Cited Works
- → Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial(2019)286 cited
- → Assessment of Liver Fibrosis with 2-D Shear Wave Elastography in Comparison to Transient Elastography and Acoustic Radiation Force Impulse Imaging in Patients with Chronic Liver Disease(2015)93 cited
- → Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial(2023)69 cited
- → Treating hepatitis D with bulevirtide – Real-world experience from 114 patients(2023)57 cited
- → Improvement of Neurocognitive Function in Responders to an Antiviral Therapy for Chronic Hepatitis C(2013)54 cited
- → The Lipid Status in Patients with Ulcerative Colitis: Sphingolipids are Disease-Dependent Regulated(2019)39 cited
- → Primary Biliary Acids Inhibit Hepatitis D Virus (HDV) Entry into Human Hepatoma Cells Expressing the Sodium-Taurocholate Cotransporting Polypeptide (NTCP)(2015)35 cited
- → Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis—A real-world case series(2024)34 cited
- → Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial(2025)10 cited
- → Switching Vedolizumab from IV to SC Injection in Inflammatory Bowel Disease Patients with Active Disease: Real-World Experience from a German IBD Cohort(2023)8 cited